Correlation Between Boston Omaha and Cumberland Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Boston Omaha and Cumberland Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boston Omaha and Cumberland Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Boston Omaha Corp and Cumberland Pharmaceuticals, you can compare the effects of market volatilities on Boston Omaha and Cumberland Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boston Omaha with a short position of Cumberland Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boston Omaha and Cumberland Pharmaceuticals.

Diversification Opportunities for Boston Omaha and Cumberland Pharmaceuticals

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Boston and Cumberland is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Boston Omaha Corp and Cumberland Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cumberland Pharmaceuticals and Boston Omaha is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Boston Omaha Corp are associated (or correlated) with Cumberland Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cumberland Pharmaceuticals has no effect on the direction of Boston Omaha i.e., Boston Omaha and Cumberland Pharmaceuticals go up and down completely randomly.

Pair Corralation between Boston Omaha and Cumberland Pharmaceuticals

Considering the 90-day investment horizon Boston Omaha Corp is expected to under-perform the Cumberland Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Boston Omaha Corp is 1.94 times less risky than Cumberland Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Cumberland Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  215.00  in Cumberland Pharmaceuticals on September 3, 2024 and sell it today you would lose (75.00) from holding Cumberland Pharmaceuticals or give up 34.88% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Boston Omaha Corp  vs.  Cumberland Pharmaceuticals

 Performance 
       Timeline  
Boston Omaha Corp 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Boston Omaha Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Boston Omaha may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Cumberland Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cumberland Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Cumberland Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Boston Omaha and Cumberland Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Boston Omaha and Cumberland Pharmaceuticals

The main advantage of trading using opposite Boston Omaha and Cumberland Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boston Omaha position performs unexpectedly, Cumberland Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cumberland Pharmaceuticals will offset losses from the drop in Cumberland Pharmaceuticals' long position.
The idea behind Boston Omaha Corp and Cumberland Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Valuation
Check real value of public entities based on technical and fundamental data